Macrolide and tetracycline resistance in clinical strains of Streptococcus agalactiae isolated in Tunisia

Journal of Medical Microbiology

Volumn 61, Issue 8, 2012, Pages 1109-1113

  Hraoui, M ^a   Boubaker, I Boutiba Ben ^a   Rachdi, M ^a   Slim, A ^a   Ben Redjeb, S ^a  

^a UNIVERSITY OF TUNIS EL MANAR   (Tunisia)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; CHLORAMPHENICOL; CLINDAMYCIN; DALFOPRISTIN PLUS QUINUPRISTIN; ERYTHROMYCIN; GENTAMICIN; LINCOSAMIDE; LINEZOLID; MACROLIDE; MIKAMYCIN B; PENICILLIN G; RIFAMPICIN; STREPTOMYCIN; TETRACYCLINE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM ISOLATION; DRUG MECHANISM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MINIMUM INHIBITORY CONCENTRATION; NEWBORN; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL; STREPTOCOCCUS AGALACTIAE; TRANSPOSON; TUNISIA;

ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, BACTERIAL; EAR; FEMALE; GASTRIC JUICE; GENES, BACTERIAL; GENITALIA, FEMALE; GENOTYPE; HUMANS; INFANT, NEWBORN; MACROLIDES; MICROBIAL SENSITIVITY TESTS; PHENOTYPE; POLYMERASE CHAIN REACTION; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS AGALACTIAE; TETRACYCLINE; TUNISIA;

EID: 84864085598     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.037853-0     Document Type: Article

References (32)

1. Al-Sweih, N., Jamal, M., Kurdia, M., Abduljabar, R. & Rotimi, V. (2005). Antibiotic susceptibility profile of group B streptococcus (Streptococcus agalactiae) at the Maternity Hospital, Kuwait. Med Princ Pract 14, 260-263.
2. Andrews, J. I., Diekema, D. J., Hunter, S. K., Rhomberg, P. R., Pfaller, M. A., Jones, R. N. & Doern, G. V. (2000). Group B streptococci causing neonatal bloodstream infection: antimicrobial susceptibility and serotyping results from SENTRY centers in the western hemisphere. Am J Obstet Gynecol 183, 859-862.
3. Betriu, C., Culebras, E., Gómez, M., Rodríguez-Avial, I., Sánchez, B. A., Agreda, M. C. & Picazo, J. J. (2003). Erythromycin and clindamycin resistance and telithromycin susceptibility in Streptococcus agalactiae. Antimicrob Agents Chemother 47, 1112-1114.
4. Betriu, C., Culebras, E., Rodríguez-Avial, I., Gómez, M., Sánchez, B. A. & Picazo, J. J. (2004). In vitro activities of tigecycline against erythromycin-resistant Streptococcus pyogenes and Streptococcus agalactiae: mechanisms of macrolide and tetracycline resistance. Antimicrob Agents Chemother 48, 323-325.
5. Bingen, E., Doit, C., Bidet, P., Brahimi, N. & Deforche, D. (2004). Telithromycin susceptibility and genomic diversity of macrolideresistant serotype III group B streptococci isolated in perinatal infections. Antimicrob Agents Chemother 48, 677-680.
6. Chopra, I. & Roberts, M. (2001). Tetracycline antibiotics: mode of action, applications, molecular biology, and epidemiology of bacterial resistance. Microbiol Mol Biol Rev 65, 232-260.
7. Clancy, J., Petitpas, J., Dib-Hajj, F., Yuan, W., Cronan, M., Kamath, A. V., Bergeron, J. & Retsema, J. A. (1996). Molecular cloning and functional analysis of a novel macrolide-resistance determinant, mefA, from Streptococcus pyogenes. Mol Microbiol 22, 867-879.
8. CLSI (2006). Performance Standards for Antimicrobial Susceptibility Testing; 16th Informational Supplement. M100-S16. Wayne, PA: Clinical and Laboratory Standards Institute.
9. Collins, T. S., Calderon, M., Gilman, R. H., Vivar, A. & Charache, P. (1998). Group B streptococcal colonization in a developing country: its association with sexually transmitted disease and socioeconomic factors. Am J Trop Med Hyg 59, 633-636.
10. de Azavedo, J. C., McGavin, M., Duncan, C., Low, D. E. & McGeer, A. (2001). Prevalence and mechanisms of macrolide resistance in invasive and noninvasive group B streptococcus isolates from Ontario, Canada. Antimicrob Agents Chemother 45, 3504-3508.
11. De Mouy, D., Cavallo, J. D., Leclercq, R., Fabre, R. & The Aforcopi-Bio Network (2001). Antibiotic susceptibility and mechanisms of erythromycin resistance in clinical isolates of Streptococcus agalactiae: French Multicenter Study. Antimicrob Agents Chemother 45, 2400-2402.
12. Decoster, L., Frans, J., Blanckaert, H., Lagrou, K. & Verhaegen, J. (2005). Antimicrobial susceptibility of group B streptococci collected in two Belgian hospitals. Acta Clin Belg 60, 180-184.
13. DiPersio, L. P. & DiPersio, J. R. (2006). High rates of erythromycin and clindamycin resistance among OBGYN isolates of group B Streptococcus. Diagn Microbiol Infect Dis 54, 79-82.
14. Fitoussi, F., Loukil, C., Gros, I., Clermont, O., Mariani, P., Bonacorsi, S., Le Thomas, I., Deforche, D. & Bingen, E. (2001). Mechanisms of macrolide resistance in clinical group B streptococci isolated in France. Antimicrob Agents Chemother 45, 1889-1891.
15. Flannagan, S. E., Zitzow, L. A., Su, Y. A. & Clewell, D. B. (1994). Nucleotide sequence of the 18-kb conjugative transposon Tn916 from Enterococcus faecalis. Plasmid 32, 350-354.
16. Gonzalez, J. J., Andreu, A. & the Spanish Group for the Study of Perinatal Infection from the Spanish Society for Clinical Microbiology and Infectious Diseases (2005). Multicenter study of the mechanisms of resistance and clonal relationships of Streptococcus agalactiae isolates resistant to macrolides, lincosamides, and ketolides in Spain. Antimicrob Agents Chemother 49, 2525-2527.
17. Hsueh, P. R., Teng, L. J., Lee, L. N., Ho, S. W., Yang, P. C. & Luh, K. T. (2001). High incidence of erythromycin resistance among clinical isolates of Streptococcus agalactiae in Taiwan. Antimicrob Agents Chemother 45, 3205-3208.
18. Lin, F. Y., Azimi, P. H., Weisman, L. E., Philips, J. B., III, Regan, J., Clark, P., Rhoads, G. G., Clemens, J., Troendle, J. & other authors (2000). Antibiotic susceptibility profiles for group B streptococci isolated from neonates, 1995-1998. Clin Infect Dis 31, 76-79.
19. Lopardo, H. A., Vidal, P., Jeric, P., Centron, D., Paganini, H., Facklam, R. R., Elliott, J. & Argentinian Streptococcus Study Group (2003). Six-month multicenter study on invasive infections due to group B streptococci in Argentina. J Clin Microbiol 41, 4688-4694.
20. Malbruny, B., Nagai, K., Coquemont, M., Bozdogan, B., Andrasevic, A. T., Hupkova, H., Leclercq, R. & Appelbaum, P. C. (2002). Resistance to macrolides in clinical isolates of Streptococcus pyogenes due to ribosomal mutations. J Antimicrob Chemother 49, 935-939.
21. Matsubara, K., Nishiyama, Y., Katayama, K., Yamamoto, G., Sugiyama, M., Murai, T. & Baba, K. (2001). Change of antimicrobial susceptibility of group B streptococci over 15 years in Japan. J Antimicrob Chemother 48, 579-582.
22. Morales, W. J., Dickey, S. S., Bornick, P. & Lim, D. V. (1999). Change in antibiotic resistance of group B streptococcus: impact on intrapartum management. Am J Obstet Gynecol 181, 310-314.
23. Portillo, A., Lantero, M., Olarte, I., Ruiz-Larrea, F. & Torres, C. (2001). MLS resistance phenotypes and mechanisms in b-haemolytic group B, C and G Streptococcus isolates in La Rioja, Spain. J Antimicrob Chemother 47, 115-116.
24. Poyart, C., Jardy, L., Quesne, G., Berche, P. & Trieu-Cuot, P. (2003). Genetic basis of antibiotic resistance in Streptococcus agalactiae strains isolated in a French hospital. Antimicrob Agents Chemother 47, 794-797.
25. Reid, T. M. S. (1975). Emergence of group B streptococci in obstetric and perinatal infections. BMJ 2, 533-535.
26. Roberts, M. C., Sutcliffe, J., Courvalin, P., Jensen, L. B., Rood, J. & Seppala, H. (1999). Nomenclature for macrolide and macrolidelincosamide-streptogramin B resistance determinants. Antimicrob Agents Chemother 43, 2823-2830.
27. Ruess, M., Muller, U., Sander, A. & Berner, R. (2000). Antimicrobial susceptibility patterns of Streptococcus agalactiae in a German university hospital. Scand J Infect Dis 32, 623-626.
28. Sahnoun, O., Ben Abdallah, H., Noomen, S., Ben Elhadj Khélifa, A. & Mastouri, M. (2007). [Antimicrobial susceptibility of Streptococcus agalactiae strains in Monastir]. Med Mal Infect 37, 734-737 (in French).
29. Schrag, S. J., Zywicki, S., Farley, M. M., Reingold, A. L., Harrison, L. H., Lefkowitz, L. B., Hadler, J. L., Danila, R., Cieslak, P. R. & Schuchat, A. (2000). Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis. N Engl J Med 342, 15-20.
30. Seppala, H., Nissinen, A., Yu, Q. & Huovinen, P. (1993). Three different phenotypes of erythromycin-resistant Streptococcus pyogenes in Finland. J Antimicrob Chemother 32, 885-891.
31. Shabayek, S. A., Abdalla, S. M. & Abouzeid, A. M. (2009). Vaginal carriage and antibiotic susceptibility profile of group B Streptococcus during late pregnancy in Ismailia, Egypt. J Infect Public Health 2, 86-90.
32. Traub, W. H. & Leonhard, B. (1997). Comparative susceptibility of clinical group A, B, C, F, and G b-hemolytic streptococcal isolates to 24 antimicrobial drugs. Chemotherapy 43, 10-20.